#biotechnology
#biotechnology

[ follow ]

Colossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseases

Colossal Biosciences achieved a milestone by genetically engineering woolly mice, marking a significant step towards woolly mammoth de-extinction.

A startup plans to make money from reviving the woolly mammoth. Here's how.

Colossal Biosciences aims to revive extinct species, leveraging advancements in biotechnology to create new revenue streams and innovations.

Have Scientists Created Hybrids of Mice and Mammoths?

Colossal's latest project involves gene-edited mice simulating wooly mammoth traits, raising questions about de-extinction efforts.

Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'

Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.

Scientists aiming to bring back woolly mammoth create woolly mice

Scientists create genetically modified woolly mice as a step toward reviving woolly mammoths.

These scientists are trying to revive woolly mammoths ... by modifying mice

Colossal Biosciences has created genetically modified mice resembling woolly mammoths as a step toward de-extinction.

Colossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseases

Colossal Biosciences achieved a milestone by genetically engineering woolly mice, marking a significant step towards woolly mammoth de-extinction.

A startup plans to make money from reviving the woolly mammoth. Here's how.

Colossal Biosciences aims to revive extinct species, leveraging advancements in biotechnology to create new revenue streams and innovations.

Have Scientists Created Hybrids of Mice and Mammoths?

Colossal's latest project involves gene-edited mice simulating wooly mammoth traits, raising questions about de-extinction efforts.

Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'

Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.

Scientists aiming to bring back woolly mammoth create woolly mice

Scientists create genetically modified woolly mice as a step toward reviving woolly mammoths.

These scientists are trying to revive woolly mammoths ... by modifying mice

Colossal Biosciences has created genetically modified mice resembling woolly mammoths as a step toward de-extinction.

morede-extinction

For Patients Needing Transplants, Hope Arrives on Tiny Hooves

Cloned pigs are being raised in controlled conditions for potential use in human organ transplants, highlighting advances in biotechnology and ethical considerations.

'Startup Nation' Groups Say They're Meeting Trump Officials to Push for Deregulated 'Freedom Cities'

Regulatory challenges hinder technological development despite available capital and political support.

#genetic-engineering

Gene-edited non-browning banana could cut food waste, scientists say

The genetically engineered non-browning banana offers a new solution to food waste by extending shelf life and resilience during transport.

Male mosquitoes to be genetically engineered to poison females with semen in Australian research

Genetically engineered male mosquitoes can inject venom into females during mating to reduce mosquito populations and disease transmission.

Surgeons Transplant Engineered Pig Kidney Into Fourth Patient

Successful genetically modified pig kidney transplant performed on a 66-year-old man raises hopes for addressing organ shortages.

Gene-edited non-browning banana could cut food waste, scientists say

The genetically engineered non-browning banana offers a new solution to food waste by extending shelf life and resilience during transport.

Male mosquitoes to be genetically engineered to poison females with semen in Australian research

Genetically engineered male mosquitoes can inject venom into females during mating to reduce mosquito populations and disease transmission.

Surgeons Transplant Engineered Pig Kidney Into Fourth Patient

Successful genetically modified pig kidney transplant performed on a 66-year-old man raises hopes for addressing organ shortages.

moregenetic-engineering

#antibiotic-resistance

Harvard startup creating a new class of antibiotics - Harvard Gazette

Kinvard Bio aims to tackle antibiotic resistance by developing a new class of antibiotics to treat infections effectively.

Bacterial 'jumping genes' can target and control chromosome ends | Cornell Chronicle

Transposons play a crucial role in bacterial evolution and antibiotic resistance by moving within genomes.

Harvard startup creating a new class of antibiotics - Harvard Gazette

Kinvard Bio aims to tackle antibiotic resistance by developing a new class of antibiotics to treat infections effectively.

Bacterial 'jumping genes' can target and control chromosome ends | Cornell Chronicle

Transposons play a crucial role in bacterial evolution and antibiotic resistance by moving within genomes.

moreantibiotic-resistance

#investment

UK's Epoch Biodesign secures 17.1M in Series A

Epoch Biodesign raised $18.3M to enhance enzyme technology for improved plastic recycling over traditional methods.

Exclusive | Behind the billionaire-backed longevity business - and the innovations that could help us live longer

Tech billionaires are investing heavily in longevity research, turning life-extending therapeutics into a burgeoning $25 billion industry.

Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan | TechCrunch

OpenAI's CEO Sam Altman is heavily investing in biotech to extend human lifespan through disease-targeted drug development.

Leiden-based BIMINI Biotech bags 3M

BIMINI Biotech secured €3M to develop cancer therapeutics targeting WASp, addressing high relapse rates and poor outcomes in hematological cancers.

Invest-NL and Invest International invest 17.5M in Forbion fund - Silicon Canals

Invest-NL invests €7.5M in Forbion BioEconomy Fund I, targeting sustainable biotech innovations.

France's Biomemory bags 17.1M to create DNA drives

Biomemory raises $18M to advance DNA data storage technology, presenting a sustainable alternative to traditional methods.

UK's Epoch Biodesign secures 17.1M in Series A

Epoch Biodesign raised $18.3M to enhance enzyme technology for improved plastic recycling over traditional methods.

Exclusive | Behind the billionaire-backed longevity business - and the innovations that could help us live longer

Tech billionaires are investing heavily in longevity research, turning life-extending therapeutics into a burgeoning $25 billion industry.

Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan | TechCrunch

OpenAI's CEO Sam Altman is heavily investing in biotech to extend human lifespan through disease-targeted drug development.

Leiden-based BIMINI Biotech bags 3M

BIMINI Biotech secured €3M to develop cancer therapeutics targeting WASp, addressing high relapse rates and poor outcomes in hematological cancers.

Invest-NL and Invest International invest 17.5M in Forbion fund - Silicon Canals

Invest-NL invests €7.5M in Forbion BioEconomy Fund I, targeting sustainable biotech innovations.

France's Biomemory bags 17.1M to create DNA drives

Biomemory raises $18M to advance DNA data storage technology, presenting a sustainable alternative to traditional methods.

moreinvestment

China Targets U.S. Biotech Firm in Broadening Blacklist

China escalates trade conflict with the U.S. by banning Illumina, signaling a robust response to tariffs.

COVID-flu vaccine could provide broad, lasting protection | Cornell Chronicle

A new vaccine platform from Cornell researchers offers longer-lasting protection against COVID-19 and influenza, showing promising results in mouse models.

#funding

In other news this week: ZeroNorth secures 48.1M+, and more

A range of startups, including Leafr and Ignota Labs, have secured significant funding to innovate in sustainability and drug development.

Belgian firm 4Tissue raises 1.5M to advance bioresorbable hydrogel for breast reconstruction - Silicon Canals

4Tissue has secured €1.5M funding to advance bioresorbable hydrogel technology for breast reconstruction and tissue regeneration.

In other news this week: Utrecht's Happybase bags 650K, Themis secures 8.7M to combat financial crime, SNIPR Biome gets 20M from EIB and more - Silicon Canals

Startups in sectors like agritech and biotech are securing significant funding to innovate and enhance sustainability in their respective industries.

Faircraft raises 15M to develop lab-grown leather - Silicon Canals

Faircraft secures €15M funding to scale production of lab-grown leather.

The startup aims to meet rising demand through team expansion and innovative processes.

National Growth Fund invests 1.4M in seven Twente-based biotech projects

Seven biotechnology projects from Twente received €1.4M funding, highlighting regional innovation and leadership in biotechnology.

French firm Bioptimus bags 74M - Silicon Canals

Bioptimus has secured $76M funding to enhance its AI platform for biological research, aiming to transform understanding and simulation of biology.

In other news this week: ZeroNorth secures 48.1M+, and more

A range of startups, including Leafr and Ignota Labs, have secured significant funding to innovate in sustainability and drug development.

Belgian firm 4Tissue raises 1.5M to advance bioresorbable hydrogel for breast reconstruction - Silicon Canals

4Tissue has secured €1.5M funding to advance bioresorbable hydrogel technology for breast reconstruction and tissue regeneration.

In other news this week: Utrecht's Happybase bags 650K, Themis secures 8.7M to combat financial crime, SNIPR Biome gets 20M from EIB and more - Silicon Canals

Startups in sectors like agritech and biotech are securing significant funding to innovate and enhance sustainability in their respective industries.

Faircraft raises 15M to develop lab-grown leather - Silicon Canals

Faircraft secures €15M funding to scale production of lab-grown leather.

The startup aims to meet rising demand through team expansion and innovative processes.

National Growth Fund invests 1.4M in seven Twente-based biotech projects

Seven biotechnology projects from Twente received €1.4M funding, highlighting regional innovation and leadership in biotechnology.

French firm Bioptimus bags 74M - Silicon Canals

Bioptimus has secured $76M funding to enhance its AI platform for biological research, aiming to transform understanding and simulation of biology.

morefunding

#stock-market

The Billionaire Baker Brothers Just Made This Big Biotech Stock Move

Billionaires Julian and Felix Baker significantly influence biotech investments through their hedge fund, Baker Bros. Advisors.

Prediction: This Pharma Stock Will Be the Best Performer in 2025

Market uncertainty deters investors from speculative industries; however, many biotech stocks are undervalued and present opportunities.

Viking Therapeutics shows significant stock growth since its IPO and is anticipated to continue this upward trend.

The Billionaire Baker Brothers Just Made This Big Biotech Stock Move

Billionaires Julian and Felix Baker significantly influence biotech investments through their hedge fund, Baker Bros. Advisors.

Prediction: This Pharma Stock Will Be the Best Performer in 2025

Market uncertainty deters investors from speculative industries; however, many biotech stocks are undervalued and present opportunities.

Viking Therapeutics shows significant stock growth since its IPO and is anticipated to continue this upward trend.

morestock-market

#startup-funding

Tech firms are cashing in on the bizarre science of organ preservation

The evolution of organ transplantation technology is creating new business opportunities.

OrganOx's innovative liver preservation technology enhances transplant success rates by extending organ viability.

Xenotransplantation using gene-edited pig organs is emerging as a solution for organ shortages.

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunch

Afynia Laboratories aims to revolutionize endometriosis diagnosis with a novel blood test utilizing microRNA biomarkers.

UK & US-based healthtech startup Level Zero Health bags 6.63M

Level Zero Health has secured £5.5M in pre-seed funding to develop continuous hormone monitoring technology using DNA-based sensors.

The Weekly Notable Startup Funding Report: 1/13/25

Notable startup funding in various sectors totaled $1.3B, showcasing innovation and investment across multiple industries, including biotechnology and healthcare.

Tech firms are cashing in on the bizarre science of organ preservation

The evolution of organ transplantation technology is creating new business opportunities.

OrganOx's innovative liver preservation technology enhances transplant success rates by extending organ viability.

Xenotransplantation using gene-edited pig organs is emerging as a solution for organ shortages.

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunch

Afynia Laboratories aims to revolutionize endometriosis diagnosis with a novel blood test utilizing microRNA biomarkers.

UK & US-based healthtech startup Level Zero Health bags 6.63M

Level Zero Health has secured £5.5M in pre-seed funding to develop continuous hormone monitoring technology using DNA-based sensors.

The Weekly Notable Startup Funding Report: 1/13/25

Notable startup funding in various sectors totaled $1.3B, showcasing innovation and investment across multiple industries, including biotechnology and healthcare.

morestartup-funding

#drug-discovery

Four ways to power-up AI for drug discovery

AI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.

Deepmind scientist raises $50m to use AI in protein design revolution

Latent Labs aims to revolutionize protein design and drug discovery using AI technology developed by former DeepMind scientist Simon Kohl.

Four ways to power-up AI for drug discovery

AI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.

Deepmind scientist raises $50m to use AI in protein design revolution

Latent Labs aims to revolutionize protein design and drug discovery using AI technology developed by former DeepMind scientist Simon Kohl.

moredrug-discovery

#fda-approval

Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity - MedCity News

Bluebird Bio has agreed to sell itself to private equity firms Carlyle and SK Capital for $29 million to stabilize its gene therapy commercialization efforts.

This Blood Vessel Was Grown in a Lab With Real Human Cells

Humacyte has developed a bioengineered blood vessel to help avoid amputation in patients with vascular trauma.

Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity - MedCity News

Bluebird Bio has agreed to sell itself to private equity firms Carlyle and SK Capital for $29 million to stabilize its gene therapy commercialization efforts.

This Blood Vessel Was Grown in a Lab With Real Human Cells

Humacyte has developed a bioengineered blood vessel to help avoid amputation in patients with vascular trauma.

morefda-approval

Bold red lipstick gets its color from crushed bugs. This biotech startup made a version that's insect-free

The classic red color of lipstick traditionally comes from carmine, but a new biotech alternative has emerged without using insects.

US court upholds Theranos founder Elizabeth Holmes's conviction

Elizabeth Holmes's conviction for defrauding investors in Theranos is upheld by a U.S. court, rejecting her appeal against the ruling.

#ai

NVIDIA and Arc Institute Unveil Evo 2, a Groundbreaking Foundation Model for Biomolecular Sciences

Evo 2 is a groundbreaking AI model set to enhance biomolecular research through genomic data analysis.

Why "Living Intelligence" Is the Next Big Thing

Companies must recognize the convergence of AI, advanced sensors, and biotechnology to stay relevant in the evolving technological landscape.

Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunch

Latent Labs is advancing AI to revolutionize protein design for biotech and pharmaceutical applications.

NVIDIA and Arc Institute Unveil Evo 2, a Groundbreaking Foundation Model for Biomolecular Sciences

Evo 2 is a groundbreaking AI model set to enhance biomolecular research through genomic data analysis.

Why "Living Intelligence" Is the Next Big Thing

Companies must recognize the convergence of AI, advanced sensors, and biotechnology to stay relevant in the evolving technological landscape.

Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunch

Latent Labs is advancing AI to revolutionize protein design for biotech and pharmaceutical applications.

moreai

#innovation

Why is it so hard to rewrite a genome?

Synthetic genomics has progressed significantly since the failed Big DNA Contest in 2004, demonstrating the importance of ambition and imagination in research.

This MIT spinout wants to spool hair-thin fibers into patients' brains | TechCrunch

NeuroBionics seeks to revolutionize treatment for neurological conditions through minimally invasive neuromodulation therapies using advanced materials.

Loreal's latest device promises to help find out how well your skin responds to ingredients like retinol

L'Oréal's Cell BioPrint analyzes skin to offer personalized anti-aging advice, leveraging proteomics technology.

Meet WanderlusTea, Coffee Resurrect & Unbench: HackerNoon Startups Of The Week | HackerNoon

HackerNoon's Startups of The Week highlights innovative companies making significant impacts in their sectors.

Scientist Testing Spider-Man-Style Web Shooters He Accidentally Made in Lab

Researchers created a new adhesive inspired by nature that mimics Spider-Man's web-shooting abilities.

The discovery of a material that can remotely capture objects opens new possibilities in biotechnology.

UK must do more to lead innovation in bio-tech sector, Lords committee says

The UK must enhance its innovation in engineering biology to remain competitive on a global scale.

Why is it so hard to rewrite a genome?

Synthetic genomics has progressed significantly since the failed Big DNA Contest in 2004, demonstrating the importance of ambition and imagination in research.

This MIT spinout wants to spool hair-thin fibers into patients' brains | TechCrunch

NeuroBionics seeks to revolutionize treatment for neurological conditions through minimally invasive neuromodulation therapies using advanced materials.

Loreal's latest device promises to help find out how well your skin responds to ingredients like retinol

L'Oréal's Cell BioPrint analyzes skin to offer personalized anti-aging advice, leveraging proteomics technology.

Meet WanderlusTea, Coffee Resurrect & Unbench: HackerNoon Startups Of The Week | HackerNoon

HackerNoon's Startups of The Week highlights innovative companies making significant impacts in their sectors.

Scientist Testing Spider-Man-Style Web Shooters He Accidentally Made in Lab

Researchers created a new adhesive inspired by nature that mimics Spider-Man's web-shooting abilities.

The discovery of a material that can remotely capture objects opens new possibilities in biotechnology.

UK must do more to lead innovation in bio-tech sector, Lords committee says

The UK must enhance its innovation in engineering biology to remain competitive on a global scale.

moreinnovation

#synthetic-biology

AI used to design a multi-step enzyme that can digest some plastics

The enzyme design process improved significantly with PLACER screening, resulting in enzymes that could perform multiple reactions.

Scientists Horrified by "Mirror Life" That Could Wipe Out Biology As We Know It

Mirror life technology poses existential risks that could endanger life on Earth, warranting immediate pause in research efforts.

Scientist reveals gruesome way mirror bacteria could take over body

The development of synthetic 'mirror bacteria' poses a significant risk to human health, potentially causing untreatable infections and blockages in the body.

Audio long read: AI has dreamt up a blizzard of new proteins. Do any of them actually work?

AI tools drastically enhance protein design, but they overwhelm lab testing capacities, necessitating competitions to filter realistic solutions.

Scientists use AI to design life-like enzymes from scratch

AI can design novel enzymes that perform multi-step reactions effectively, revolutionizing enzyme engineering.

AI used to design a multi-step enzyme that can digest some plastics

The enzyme design process improved significantly with PLACER screening, resulting in enzymes that could perform multiple reactions.

Scientists Horrified by "Mirror Life" That Could Wipe Out Biology As We Know It

Mirror life technology poses existential risks that could endanger life on Earth, warranting immediate pause in research efforts.

Scientist reveals gruesome way mirror bacteria could take over body

The development of synthetic 'mirror bacteria' poses a significant risk to human health, potentially causing untreatable infections and blockages in the body.

Audio long read: AI has dreamt up a blizzard of new proteins. Do any of them actually work?

AI tools drastically enhance protein design, but they overwhelm lab testing capacities, necessitating competitions to filter realistic solutions.

Scientists use AI to design life-like enzymes from scratch

AI can design novel enzymes that perform multi-step reactions effectively, revolutionizing enzyme engineering.

moresynthetic-biology

#artificial-intelligence

Are Human Neurons AI's Future?

The development of 'wetware' technology could revolutionize artificial intelligence by utilizing biological neurons instead of traditional silicon chips.

Why tomorrow's breakthroughs will come from polyintelligent thinking

The convergence of human, machine, and nature's intelligence offers unprecedented solutions to global challenges.

Rising stars in AI use robotics and automation to accelerate their work

AI serves as a powerful tool to enhance scientific research rather than replace scientists.

Are Human Neurons AI's Future?

The development of 'wetware' technology could revolutionize artificial intelligence by utilizing biological neurons instead of traditional silicon chips.

Why tomorrow's breakthroughs will come from polyintelligent thinking

The convergence of human, machine, and nature's intelligence offers unprecedented solutions to global challenges.

Rising stars in AI use robotics and automation to accelerate their work

AI serves as a powerful tool to enhance scientific research rather than replace scientists.

moreartificial-intelligence

#intellectual-property

Federal Circuit Upholds ITC Import Ban: Key Rulings on Storage Defense and Domestic Industry Requirements

The Federal Circuit supported Ventria's patent rights against Wuhan Healthgen's importation of infringing products, reinforcing protection for small biotech companies.

Other Barks & Bites for Friday, February 7: CAFC Rejects Untimely Expert Testimony and Reassigns Case; CJEU Clarifies Online Marketplace Responsibilities Under GDPR; and IPWATCHPUPPIES ARE ON THE WAY!

The article discusses important developments in intellectual property law, showcasing recent rulings and trends affecting both the U.S. and European landscapes.

Federal Circuit Upholds ITC Import Ban: Key Rulings on Storage Defense and Domestic Industry Requirements

The Federal Circuit supported Ventria's patent rights against Wuhan Healthgen's importation of infringing products, reinforcing protection for small biotech companies.

Other Barks & Bites for Friday, February 7: CAFC Rejects Untimely Expert Testimony and Reassigns Case; CJEU Clarifies Online Marketplace Responsibilities Under GDPR; and IPWATCHPUPPIES ARE ON THE WAY!

The article discusses important developments in intellectual property law, showcasing recent rulings and trends affecting both the U.S. and European landscapes.

moreintellectual-property

Leen Kawas on Resilience as Strategy: The Role of Female Leadership in Transformative Change

Women in leadership roles bring unique perspectives that enhance organizational transformation through adaptability and emotional intelligence.

EIB backs GreenLight Biosciences with 35M loan to replace traditional chemical pesticides using power of RNA - Silicon Canals

GreenLight Biosciences España secures €35M loan from EIB to advance RNA-based agricultural solutions.

#health

The Centuries-Old, Incredibly Male Quest to Live Forever

The longevity industry is experiencing unprecedented growth, reflecting a societal obsession with extending human life significantly beyond current limits.

Growth Hormone Therapy Market Set to Double by 2032 - Here's Why

The growth hormone therapy market is rapidly expanding due to technological advancements and increased consumer demand.

The Centuries-Old, Incredibly Male Quest to Live Forever

The longevity industry is experiencing unprecedented growth, reflecting a societal obsession with extending human life significantly beyond current limits.

Growth Hormone Therapy Market Set to Double by 2032 - Here's Why

The growth hormone therapy market is rapidly expanding due to technological advancements and increased consumer demand.

morehealth

Groundbreaking': scientists develop patch that can repair damaged hearts

Researchers have developed implantable patches to treat heart failure using laboratory-grown heart muscle, offering new hope for patients.

The patches made from reprogrammed blood cells are a breakthrough in biological transplants for heart conditions.

Federal Circuit (Again) Upholds Ravgen's Fetal DNA cffDNA Patent

The Federal Circuit upheld the validity of Ravgen's fetal DNA testing patent and clarified standing requirements for appealing IPR decisions.

An Entire Book Was Written in DNA-and You Can Buy It for $60

DNA presents a highly compact solution for data storage, being at least 1,000 times more efficient than current hard drives.

Ramaswamy Has a High-Profile Perch and a Raft of Potential Conflicts

Ramaswamy's financial interests present potential conflicts as he influences federal policies.

Microbes can colonize space, produce drugs and create energy researchers are simulating their inner workings to harness how

Researchers are digitally recreating microbial processes to more efficiently produce useful chemicals for various industries.

Amsterdam-based biotech company uniQure sets this share price for 73M public offering: Know more - Silicon Canals

uniQure plans to raise $75M through a public offering amid promising progress in gene therapies for Huntington's disease.

Russia's security service says jailed American leaked biotechnology secrets

Eugene Spector sentenced to 15 years in Russia for leaking U.S.-sought biotechnology secrets, reflecting escalating tensions between the U.S. and Russia.

#longevity

Why Sleep Is the Key to Living Longer

Prioritizing healthspan is essential for living a long, healthy life, and current research and innovation are paving the way for revolutionary aging solutions.

Scientists explore longevity drugs for dogs that could also extend human life'

Dogs can significantly impact their owners' health; biotech advancements aim to extend healthy lifespans for both dogs and humans.

Why Sleep Is the Key to Living Longer

Prioritizing healthspan is essential for living a long, healthy life, and current research and innovation are paving the way for revolutionary aging solutions.

Scientists explore longevity drugs for dogs that could also extend human life'

Dogs can significantly impact their owners' health; biotech advancements aim to extend healthy lifespans for both dogs and humans.

morelongevity

#venture-capital

Amsterdam deep tech startups that raised 1M & more in 2024

Deep tech companies in the Netherlands are thriving, with increased investments and significant growth despite challenges in scaling.

Lux's Josh Wolfe on launching Lux Labs and making science fiction reality

Lux Capital supports innovative startups, especially Variant Bio, which develops therapies based on the genes of medically relevant outliers.

Amsterdam deep tech startups that raised 1M & more in 2024

Deep tech companies in the Netherlands are thriving, with increased investments and significant growth despite challenges in scaling.

Lux's Josh Wolfe on launching Lux Labs and making science fiction reality

Lux Capital supports innovative startups, especially Variant Bio, which develops therapies based on the genes of medically relevant outliers.

moreventure-capital

#entrepreneurship

These L.A. musicians investigated a medical mystery. What they discovered launched a new skincare line

A fungal infection inspired musicians Ann Marie Simpson-Einziger and Mike Einziger to pursue scientific discovery, resulting in the founding of a biotech beauty company.

Tetsuwan Scientific is making robotic AI scientists that can run experiments on their own | TechCrunch

Cristian Ponce and Theo Schäfer founded Tetsuwan Scientific to automate genetic engineering lab processes using modified robots and AI technology.

These L.A. musicians investigated a medical mystery. What they discovered launched a new skincare line

A fungal infection inspired musicians Ann Marie Simpson-Einziger and Mike Einziger to pursue scientific discovery, resulting in the founding of a biotech beauty company.

Tetsuwan Scientific is making robotic AI scientists that can run experiments on their own | TechCrunch

Cristian Ponce and Theo Schäfer founded Tetsuwan Scientific to automate genetic engineering lab processes using modified robots and AI technology.

moreentrepreneurship

Patients are so sick and tired of waiting years for a transplant that they're signing up in droves to receive vital organs from pigs

Xenotransplantation offers potential solutions to human organ shortages through the genetic modification of animals.

The strange future of lab-grown meat involves quail, crocodile, and woolly mammoth

Vow's quail parfait represents a radical shift in food technology with lab-grown meat, prioritizing sustainability and innovative production methods.

#layoffs

Cambridge company is laying of 180 people, 65% of its workforce

Editas Medicine is laying off 65% of its workforce to focus on in vivo gene editing.

As 23andMe Crumbles, It Ceases All Efforts to Develop Drugs Using DNA Data

23andMe is restructuring, laying off 40% of its workforce, and abandoning its therapeutics program amidst severe financial struggles.

Cambridge company is laying of 180 people, 65% of its workforce

Editas Medicine is laying off 65% of its workforce to focus on in vivo gene editing.

As 23andMe Crumbles, It Ceases All Efforts to Develop Drugs Using DNA Data

23andMe is restructuring, laying off 40% of its workforce, and abandoning its therapeutics program amidst severe financial struggles.

morelayoffs

#robotics

A Bionic Leg Controlled by the Brain

Advanced prosthetics leverage carbon fibre, technology, and biological engineering to enhance human capabilities significantly.

Can robotic lab assistants speed up your work?

Automation and robotics are revolutionizing the efficiency of microbial processes in research by drastically increasing throughput and reducing manual errors.

A Bionic Leg Controlled by the Brain

Advanced prosthetics leverage carbon fibre, technology, and biological engineering to enhance human capabilities significantly.

Can robotic lab assistants speed up your work?

Automation and robotics are revolutionizing the efficiency of microbial processes in research by drastically increasing throughput and reducing manual errors.

morerobotics

Man who defrauded biotech company of 840,000 jailed for over three years

Adrianus Kees pled guilty to fraud that involved a scheme to extract funds from Ovagen under the guise of securing a loan.

Leiden-based biotech company VitroScan secures 1.9M from National Growth Fund's Biotech Booster program - Silicon Canals

VitroScan secures €1.9M funding to enhance chemotherapy response prediction for ovarian cancer patients, preparing for clinical application.

Biotech Booster aims to commercialize biotechnology research through funding, mentorship, and collaboration.

10 Major North Carolina Industries to Consider if You're Working in or Moving to the Tar Heel State

North Carolina offers diverse career opportunities in thriving industries like biotechnology and IT, making it attractive for job seekers and homebuyers.

#clinical-trials

Trial of Controversial Alzheimer's Drug Halted After Disappointing Results

Cassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.

InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC

InxMed is developing ifebemtinib to enhance ADC effectiveness by reducing fibrotic barriers in tumors.

Trial of Controversial Alzheimer's Drug Halted After Disappointing Results

Cassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.

InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC

InxMed is developing ifebemtinib to enhance ADC effectiveness by reducing fibrotic barriers in tumors.

moreclinical-trials

Scavengers hold the secret to fighting infections

Scavengers recycle organic matter, helping ecosystems by feeding on waste, and are studied for their unique adaptations to consuming decaying food safely.

The Quest for Immortality: What Do Scientists Say?

Advancements in biotechnology, AI, and regenerative medicine bring humanity closer to understanding and potentially extending life indefinitely.

Bone Marrow Donors Can Be Hard to Find. One Company Is Turning to Cadavers

Ossium Health is pioneering stem cell transplants from deceased donors, addressing the donor shortage for blood cancer patients, particularly minorities.

Give a dog a clone: Couple to spend 40,000 to bring their beloved pet back to life

Cloning pets, though expensive and legal in the US, reflects deep emotional connections owners have with their animals.

[ Load more ]

#biotechnology#biotechnology

Colossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseases

A startup plans to make money from reviving the woolly mammoth. Here's how.

Have Scientists Created Hybrids of Mice and Mammoths?

Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'

Scientists aiming to bring back woolly mammoth create woolly mice

These scientists are trying to revive woolly mammoths ... by modifying mice

Colossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseases

A startup plans to make money from reviving the woolly mammoth. Here's how.

Have Scientists Created Hybrids of Mice and Mammoths?

Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'

Scientists aiming to bring back woolly mammoth create woolly mice

These scientists are trying to revive woolly mammoths ... by modifying mice

For Patients Needing Transplants, Hope Arrives on Tiny Hooves

'Startup Nation' Groups Say They're Meeting Trump Officials to Push for Deregulated 'Freedom Cities'

Gene-edited non-browning banana could cut food waste, scientists say

Male mosquitoes to be genetically engineered to poison females with semen in Australian research

Surgeons Transplant Engineered Pig Kidney Into Fourth Patient

Gene-edited non-browning banana could cut food waste, scientists say

Male mosquitoes to be genetically engineered to poison females with semen in Australian research

Surgeons Transplant Engineered Pig Kidney Into Fourth Patient

Harvard startup creating a new class of antibiotics - Harvard Gazette

Bacterial 'jumping genes' can target and control chromosome ends | Cornell Chronicle

Harvard startup creating a new class of antibiotics - Harvard Gazette

Bacterial 'jumping genes' can target and control chromosome ends | Cornell Chronicle

UK's Epoch Biodesign secures 17.1M in Series A

Exclusive | Behind the billionaire-backed longevity business - and the innovations that could help us live longer

Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan | TechCrunch

Leiden-based BIMINI Biotech bags 3M

Invest-NL and Invest International invest 17.5M in Forbion fund - Silicon Canals

France's Biomemory bags 17.1M to create DNA drives

UK's Epoch Biodesign secures 17.1M in Series A

Exclusive | Behind the billionaire-backed longevity business - and the innovations that could help us live longer

Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan | TechCrunch

Leiden-based BIMINI Biotech bags 3M

Invest-NL and Invest International invest 17.5M in Forbion fund - Silicon Canals

France's Biomemory bags 17.1M to create DNA drives

China Targets U.S. Biotech Firm in Broadening Blacklist

COVID-flu vaccine could provide broad, lasting protection | Cornell Chronicle

In other news this week: ZeroNorth secures 48.1M+, and more

Belgian firm 4Tissue raises 1.5M to advance bioresorbable hydrogel for breast reconstruction - Silicon Canals

In other news this week: Utrecht's Happybase bags 650K, Themis secures 8.7M to combat financial crime, SNIPR Biome gets 20M from EIB and more - Silicon Canals

Faircraft raises 15M to develop lab-grown leather - Silicon Canals

National Growth Fund invests 1.4M in seven Twente-based biotech projects

French firm Bioptimus bags 74M - Silicon Canals

In other news this week: ZeroNorth secures 48.1M+, and more

Belgian firm 4Tissue raises 1.5M to advance bioresorbable hydrogel for breast reconstruction - Silicon Canals

In other news this week: Utrecht's Happybase bags 650K, Themis secures 8.7M to combat financial crime, SNIPR Biome gets 20M from EIB and more - Silicon Canals

Faircraft raises 15M to develop lab-grown leather - Silicon Canals

National Growth Fund invests 1.4M in seven Twente-based biotech projects

French firm Bioptimus bags 74M - Silicon Canals

The Billionaire Baker Brothers Just Made This Big Biotech Stock Move

Prediction: This Pharma Stock Will Be the Best Performer in 2025

The Billionaire Baker Brothers Just Made This Big Biotech Stock Move

Prediction: This Pharma Stock Will Be the Best Performer in 2025

Tech firms are cashing in on the bizarre science of organ preservation

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunch

UK & US-based healthtech startup Level Zero Health bags 6.63M

The Weekly Notable Startup Funding Report: 1/13/25

Tech firms are cashing in on the bizarre science of organ preservation

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunch

UK & US-based healthtech startup Level Zero Health bags 6.63M

The Weekly Notable Startup Funding Report: 1/13/25

Four ways to power-up AI for drug discovery

Deepmind scientist raises $50m to use AI in protein design revolution

Four ways to power-up AI for drug discovery

Deepmind scientist raises $50m to use AI in protein design revolution

Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity - MedCity News

This Blood Vessel Was Grown in a Lab With Real Human Cells

Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity - MedCity News

This Blood Vessel Was Grown in a Lab With Real Human Cells

Bold red lipstick gets its color from crushed bugs. This biotech startup made a version that's insect-free

US court upholds Theranos founder Elizabeth Holmes's conviction

NVIDIA and Arc Institute Unveil Evo 2, a Groundbreaking Foundation Model for Biomolecular Sciences

Why "Living Intelligence" Is the Next Big Thing

Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunch

NVIDIA and Arc Institute Unveil Evo 2, a Groundbreaking Foundation Model for Biomolecular Sciences

Why "Living Intelligence" Is the Next Big Thing

Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunch

Why is it so hard to rewrite a genome?

#biotechnology
#biotechnology